The HCPLive Geriatric medicine condition center page is a comprehensive resource for clinical news and insights on frequent geriatric-related diseases and conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for sleep disorder, dementia, Alzheimer's disease, and more.
April 25th 2024
The fracture risk is greater for nursing home residents with dementia, greater baseline blood pressure values, and no recent antihypertensive medication use, a new study found.
Earn CME Credits While Advancing Your Expertise in Internal Medicine
April 18-19, 2024
Register Now!
The Expanding Role of Fluid Biomarkers in the Diagnosis and Management of Patients With Alzheimer Disease
View More
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
View More
Improving Care for Patients with Motor Complications of Parkinson Disease: Role of Technology and Data
View More
Clinical Consultations™: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis
View More
Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing
View More
Evolving Perspectives in Alzheimer's Disease: Reaching an Earlier Diagnosis, Understanding Neuroinflammation, and Exploring Therapeutic Advances
September 15, 2024
Register Now!
Mastering MS: Translating Evidence into Optimal Management Plans
View More
Advances In Treating Migraine in Your OB/GYN Practice: Navigating Treatment Paradigms to Improve Patient Care
View More
Recognizing Rett Syndrome Early to Improve Long-term Management Outcomes
View More
5th Annual International Congress on the Future of Neurology®
View More
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Advances In™ Generalized Myasthenia Gravis: Improving Patient Outcomes Through Early Diagnosis and Management
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
Community Practice Connections™: Transforming Multiple Sclerosis Care – Clinical Updates on the Effects of BTK Inhibitors
View More
Burst CME: Optimizing Therapy in Parkinson’s Disease
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Burst Expert Illustrations & Commentary™ : Visualizing the Role of the Complement Proteins in Neurologic Disorders
View More
Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients
View More
Burst Expert Illustrations & Commentary™: Visualizing the Role of the Complement Pathway in Neurological Disorders
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Burst Expert Illustrations & Commentary™: Visualizing the Implications of Anti-Complement Therapies on Generalized Myasthenia Gravis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Individualizing Treatment for Patients with Generalized Myasthenia Gravis
View More
Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans
View More
Clinical ShowCase™ in ALS: Addressing Diagnostic Delays, Evolving Therapies, and Multidisciplinary Care
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Recent Trial: Ranibizumab Did Not Prevent New Macular Atrophy in Cases of Neovascular AMD
Whether injected monthly or according to a TREX regimen, ranibizumab did not have a statistically significant effect on the development of new macular atrophy in eyes with neovascular AMD.
Studies Conflict on Ranibizumab's Stroke Risk
In a new study, stroke occurred in 6.6% of the ranibizumab-treated group, compared with 7.0% of the controls matched by sociodemographic factors and comorbidities and 6.7% of the controls matched by sociodemographic factors only. These differences were not statistically significant.
Mediterranean Diet May Deter Macular Degeneration
A recent study joins an ever-deepening well of data about the health benefits of the Mediterranean diet, including its risk-reduction potential for age-related macular degeneration. AMD is the leading cause of blindness in the developed world.
Patients See Benefits of Technological Advances in Ophthalmology
As with most surgical advances, new potential procedures in ophthalmology pose their fair share of risks. However, if those risks can be overcome the rewards to patients can make a significant difference in their quality of life.
Finding New Uses for ARGUS Technology in Age-Related Macular Degeneration
As a retinal implant, the ARGUS II technology has shown early benefits for patients with retinitis pigmentosa. A new study from the United Kingdom is examining its benefits in patients with the dry form of age related macular degeneration.
Weighing Safety Risks and Efficacy of New Vitrectomy Procedure Option
As with all new technologies for surgical procedures, there will be questions to be answered about the safety for hypersonic vitrectomy. While human trials have not started yet, there are good indications in cadaveric and animal studies.
High-Fat Diets Alter Gut Microbiota, Leading to Increased Choroidal Neovascularization
Research using mouse models demonstrated that a high-fat diet increased intestinal permeability, which led to increases in circulating and local inflammatory cytokines, and increased choroidal neovascularization.
Subretinal Gene Therapy Improves Vision in Patients with Wet Age-Related Macular Degeneration
Treatment with recombinant adeno-associated virus vector gene-therapy was shown to be safe and potentially effective in a small test group of patients with neovascular age-related macular degeneration.
New Telemedicine Screening Program Looks to Improve Treatment of Diabetic Retinopathy
As part of their overall health management, patients with diabetes are encouraged to undergo annual eye exams. While not all patients follow this direction, research is being done to better improve their eye health by working with their general practitioners.
Taking Treatment from the Lab to the Clinic: Rishi Singh from Cleveland Clinic
In many, if not most cases, there can be a break in the chain between researchers and the doctors they are developing treatments for. When that divide does not exist it can mean more direct access for doctors and patients to the latest treatments even in the development stages.
Treating Wet Age-Related Macular Degeneration Making Great Strides
The treatment of wet age-related macular degeneration has come a long way in a short period of time. While it may take some explaining that injections in the eye are the best way to treat the condition now there is work being done to find better ways for the future.
Aflibercept and Ranibizumab Produce Similar Improvement in Visual Acuity, According to Recent Study
A large observational study of results in routine clinical practice showed that visual acuity outcomes 12 months after Aflibercept or Ranibizumab treatment did not differ, and neither did the number of injections required for each agent.
Study Identifies Predictive Factors for Efficacy of Anti-VEGF Injections
The only factor that predicted visual outcomes one year after nAMD diagnosis was baseline visual acuity, which maintained its predictive ability five years after diagnosis. Visual acuity increased more frequently in women.
Resvega Improved Retinal Structure, Stabilized Visual Acuity in Neovascular AMD Case Study
In an 84-year-old woman with AMD and acute deterioration in vision, the oral antioxidant supplement Resvega led to regression of subretinal fluid and eliminated the need for intravitreal injection of an anti-VEGF agent over the course of 9 months.
An optical coherence tomography study found that, after three monthly treatments,aAflibercept was 7 times more effective than ranibizumab in resolving serous pigment epithelium detachment, though neither treatment improved visual acuity in these patients to a statistically significant degree.
Tissue Plasminogen Activator Yields Results for Wet AMD-Related Thick Subfoveal Hemorrhage
Vitrectomy plus subretinal injection of tissue plasminogen activator (tPA) reduced scar area moreso than pneumatic displacement plus intravitreal injection of tPA. Visual acuity improved noticeably after both of these treatments, but not after treatment with pneumatic displacement alone.
In Neovascular Age-Related Macular Degeneration, Lucentis and Eylea Yield Similar Injection Burden
After 12 months of follow-up, a Japanese team found a trend toward greater BCVA improvement in the Eylea group than in the Lucentis group but no statistically significant differences between groups in BCVA or central foveal thickness.
Flying Eye Hospital Brings Invaluable Resources to Patients Worldwide
The treatment of various eye conditions can vary widely depending on where a patient lives. While some countries may have the best technology readily available others are lacking in not only equipment but training.